Skip to main content
Daesung Microbiological Labs. Co. Ltd logo

Daesung Microbiological Labs. Co. Ltd — Investor Relations & Filings

Ticker · 036480 ISIN · KR7036480002 KO Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2020-03-11 Audit Report / Informat…
Country KR South Korea
Listing KO 036480

About Daesung Microbiological Labs. Co. Ltd

https://eng.dsmbio.co.kr/

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a short regulatory filing (under 2,100 characters) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary table of financial data and audit opinions as required by Korean regulatory standards, serving as an announcement that the audit report has been submitted to the regulator. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2019
2020-03-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Report on the Reason for Holding a General Meeting of Shareholders on a Concentrated Date'. It explains why the company scheduled its AGM on a date that coincides with many other companies' AGMs, citing audit and board scheduling constraints. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2020-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Daesung Microbiological Labs. It outlines the date, location, agenda items (including financial statement approval, director appointments, and remuneration limits), and details regarding the board of directors. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of upcoming voting items.
2020-02-25 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Daesung Microbiological Labs regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend yield, the record date, and the board resolution date. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2020-02-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership (specifically a decrease in holdings by Korea Securities Finance Corp in Daesung Microbiological Labs). This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-10 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Daesung Microbiological Labs) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) with the Public Procurement Service. This type of disclosure regarding material business contracts does not fit into specific categories like financial reports, dividends, or director dealings. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2020-01-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.